#remdesivir

The antiviral drug is the first treatment for the new coronavirus to be approved in United States.

None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.

The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.

More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.

Dexamethasone reduced mortality by up to a third among severely ill patients who needed supplemental oxygen or ventilators.

Results from randomized clinical trials of the antiviral drug continue to show mixed results.

Gilead Sciences is giving its antiviral remdesivir to nearly 1,000 people as part of two clinical trials.